FMR CORP 13D/13G Filings for Stoke Therapeutics, Inc. (STOK)

FMR CORP 13D and 13G filings for Stoke Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-02-09
09:49 am
Sale		 2024-02-08 13G Stoke Therapeutics, Inc.
STOK		 FMR CORP 5,000
0.011%		 -3,029,649decrease
(-99.84%)		 Filing
2023-02-09
12:31 pm
Purchase		 2023-02-09 13G Stoke Therapeutics, Inc.
STOK		 FMR CORP 3,034,649
7.696%		 479,850increase
(+18.78%)		 Filing
2022-02-09
10:01 am
Sale		 2022-02-08 13G Stoke Therapeutics, Inc.
STOK		 FMR CORP 2,554,799
6.944%		 -1,046,176decrease
(-29.05%)		 Filing
2021-02-08
10:33 am
Purchase		 2021-02-05 13G Stoke Therapeutics, Inc.
STOK		 FMR CORP 3,600,975
9.937%		 3,600,975increase
(New Position)		 Filing